Lidwine Wémeau-Stervinou

Author

Also Known As

L Wemeau-Stervinou, L. Wemeau-Stervinou, L. Wémeau-Stervinou, L., Wémeau-Stervinou, Lidwine Wemeau-Stervinou, Lidwine Wémeau-Stervinou

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Inserm Centre Hospitalier Universitaire de Lille Hôpital Bichat-Claude-Bernard Assistance Publique – Hôpitaux de Paris Université Paris Cité

About

Lidwine Wémeau-Stervinou is an author at Inserm specializing in medicine, lung cancer, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	458
2	Cell Biology	2	2	220
3	Health Sciences	1	1	110
4	Public Health	1	1	22
5	Emergency Medicine	1	1	22

Lidwine Wémeau-Stervinou

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease Pierre‐Antoine Juge, Joyce Lee, Esther Ebstein, New England Journal of Medicine	2018	475
Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis Pierre‐Antoine Juge, Raphaël Borie, Caroline Kannengiesser, European Respiratory Journal	2017	225
Prevalence and characteristics of <i>TERT</i> and <i>TERC</i> mutations in suspected genetic pulmonary fibrosis Raphaël Borie, Laure Tabèze, Gabriel Thabut, European Respiratory Journal	2016	170
Severe hematologic complications after lung transplantation in patients with telomerase complex mutations Raphaël Borie, Caroline Kannengiesser, Sandrine Hirschi, The Journal of Heart and Lung Transplantation TransplantationMedicineHematologyTransplantation MedicinePathology	2014	136
The Hedgehog System Machinery Controls Transforming Growth Factor-β–Dependent Myofibroblastic Differentiation in Humans Natacha Cigna, Elika Farrokhi Moshai, Stéphanie Brayer, American Journal Of Pathology Developmental BiologyTissue DevelopmentGrowth HormoneHuman GrowthMorphogenesis	2012	133
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial Julie Mankikian, Agnès Caille, Martine Reynaud‐Gaubert, European Respiratory Journal	2023	111
Physical Activity in Daily Life of Patients With Fibrotic Idiopathic Interstitial Pneumonia B. Wallaert, Emmanuel Monge, Olivier Le Rouzic, CHEST Journal Physical ActivityKinesiologyExerciseDaily LifeExercise Medicine	2013	110
The 1-minute sit-to-stand test to detect exercise-induced oxygen desaturation in patients with interstitial lung disease Justine Briand, Hélène Behal, Cécile Chenivesse, Therapeutic Advances in Respiratory Disease	2018	103
Targeting the Hedgehog–Glioma-Associated Oncogene Homolog Pathway Inhibits Bleomycin-Induced Lung Fibrosis in Mice Elika Farrokhi Moshai, Lidwine Wémeau-Stervinou, Natacha Cigna, American Journal of Respiratory Cell and Molecular Biology Acute Lung InjuryInflammatory Lung DiseaseLung Collagen AccumulationLung InflammationPathology	2014	87
Regulator of telomere length 1 (<i>RTEL1</i>) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes Raphaël Borie, Diane Bouvry, Vincent Cottin, European Respiratory Journal	2018	69

Page 1